Novo Nordisk received 3,071 prescriptions in the first four days after its January 5 U.S. debut. ・Eli Lilly said that ...

Three years ago, Eli Lilly ( LLY 2.40%) and Novo Nordisk ( NVO +1.87%) had about the same market value. Given how well both ...

As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.

Eli Lilly's oral weight-loss drug, Foundayo, nabbed 1,390 prescriptions in its first week on the market, analysts said Friday.

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology ...

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new ...

Novo Nordisk (NVO) stock is in focus as the company expands its workforce by ~2,000 YTD after major layoffs and restructuring ...

Drug maker Novo Nordisk is cutting 400 jobs at its Bloomington facility in early May. Novo Nordisk's sales are expected to fall this year, and its share price has dropped significantly. The job losses ...

Novo Nordisk has hired about 2,000 employees this year as it reshapes its workforce following last year’s record layoffs of ...

GLP-1 drugs have direct beneficial effects on the liver, independent of their benefits for obesity, researchers ‌studying the ...

Novo Nordisk is facing a federal lawsuit from a former employee who says she was fired for raising concerns about race ...